These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 21116949)

  • 21. Nanoparticle characterization for cancer nanotechnology and other biological applications.
    Brown SC; Palazuelos M; Sharma P; Powers KW; Roberts SM; Grobmyer SR; Moudgil BM
    Methods Mol Biol; 2010; 624():39-65. PubMed ID: 20217588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnological applications in medicine.
    Caruthers SD; Wickline SA; Lanza GM
    Curr Opin Biotechnol; 2007 Feb; 18(1):26-30. PubMed ID: 17254762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Nanomedicine; 2012 Sep; 8 Suppl 1():S59-68. PubMed ID: 22640906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication of solid nanoparticles for drug delivery.
    Arayne MS; Sultana N; Noor-Us-Sabah
    Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite nanoparticles take aim at cancer.
    Gil PR; Parak WJ
    ACS Nano; 2008 Nov; 2(11):2200-5. PubMed ID: 19206383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology: emerging tool for diagnostics and therapeutics.
    Chakraborty M; Jain S; Rani V
    Appl Biochem Biotechnol; 2011 Nov; 165(5-6):1178-87. PubMed ID: 21847590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications.
    Gao J; Gu H; Xu B
    Acc Chem Res; 2009 Aug; 42(8):1097-107. PubMed ID: 19476332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanotechnology in cardiovascular medicine.
    Patel DN; Bailey SR
    Catheter Cardiovasc Interv; 2007 Apr; 69(5):643-54. PubMed ID: 17390307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of nanoparticles for therapeutics.
    Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
    Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
    Eifler AC; Thaxton CS
    Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology for sensing, imaging, and treating cancer.
    Panchapakesan B; Wickstrom E
    Surg Oncol Clin N Am; 2007 Apr; 16(2):293-305. PubMed ID: 17560513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.